(Q15409409)

English

ledipasvir

chemical compound

GS5885
GS-5885
GS 5885
WHO 9796

In more languages

default for all languages

No label defined

No description defined

Statements

type of chemical entity

0 references

heterocyclic compound

0 references

carbocyclic compound

0 references

0 references

chemical structure

Ledipasvir.svg
512 × 132; 16 KB

0 references

888.413438 dalton

1 reference

language of work or name

Ledipasvir (English)

4 October 2016

chemical formula

C₄₉H₅₄F₂N₈O₆

1 reference

language of work or name

Ledipasvir (English)

19 November 2016

canonical SMILES

CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC

1 reference

language of work or name

Ledipasvir (English)

19 November 2016

isomeric SMILES

CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC

1 reference

language of work or name

Ledipasvir (English)

19 November 2016

medical condition treated

10 October 2014

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/013TE6E4WV

http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205834s000lbl.pdf

significant drug interaction

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

muscular disease

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

subject has role

xenobiotic-transporting ATPase inhibitor

1 reference

5 March 2018

antiviral agent

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

essential medicine

0 references

1 reference

1 reference

Commons category

Ledipasvir

0 references

CAS COVID-19 Anti-Viral Candidate Compounds

0 references

Identifiers

InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1

1 reference

language of work or name

Ledipasvir (English)

19 November 2016

VRTWBAAJJOHBQU-KMWAZVGDSA-N

2 references

language of work or name

Ledipasvir (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

ledipasvir (English)

19 November 2016

CAS Common Chemistry

7 April 2021

https://commonchemistry.cas.org/detail?cas_rn=1256388-51-8

VRTWBAAJJOHBQU-KMWAZVGDSA-N

1 reference

language of work or name

Ledipasvir (English)

19 November 2016

2 references

language of work or name

Ledipasvir (English)

19 November 2016

matched by identifier from

VRTWBAAJJOHBQU-KMWAZVGDSA-N

Reaxys registry number

23926149

1 reference

language of work or name

ledipasvir (English)

4 October 2016

mapping relation type

2 references

language of work or name

LEDIPASVIR (English)

19 November 2016

matched by identifier from

International Chemical Identifier

InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1

1 reference

language of work or name

LEDIPASVIR (English)

19 November 2016

SCHEMBL15116943

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

VRTWBAAJJOHBQU-KMWAZVGDSA-N

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

VRTWBAAJJOHBQU-KMWAZVGDSA-N

UniChem compound ID

1 reference

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

VRTWBAAJJOHBQU-KMWAZVGDSA-N

DSSTOX compound identifier

0 references

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

MeSH descriptor ID

subject named as

ledipasvir

1 reference

Medical Subject Headings

MeSH descriptor ID

14 March 2018

1 reference

Global Substance Registration System

language of work or name

ledipasvir (English)

19 November 2016

1 reference

matched by identifier from

VRTWBAAJJOHBQU-KMWAZVGDSA-N

2 references

Global Substance Registration System

language of work or name

ledipasvir (English)

19 November 2016

matched by identifier from

VRTWBAAJJOHBQU-KMWAZVGDSA-N

1 reference

Global Substance Registration System

language of work or name

ledipasvir (English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

ledipasvir (English)

4 October 2016

1 reference

6 April 2020

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Global Substance Registration System

language of work or name

ledipasvir (English)

19 November 2016

Sitelinks

Wikipedia(20 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Ledipasvir

Retrieved from "https://www.wikidata.org/w/index.php?title=Q15409409&oldid=2186694831"